» Articles » PMID: 20368375

Dietary Phylloquinone Intakes and Metabolic Syndrome in US Young Adults

Overview
Journal J Am Coll Nutr
Date 2010 Apr 7
PMID 20368375
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The relationship between dietary intake of vitamin K and metabolic syndrome (MetS) has not been investigated previously. The aim of this study was to examine whether and to what extent vitamin K intake measured as phylloquinone is related to MetS.

Design: We performed a cross-sectional analysis on data from 5800 adults aged 20 to 45 years who participated in the National Health and Nutrition Examination Survey (NHANES) 1999-2004. MetS was defined according to Adult Treatment Panel III criteria. Dietary phylloquinone intakes were obtained from 24-hour dietary recall. Prevalence and odds ratios (OR) of MetS and its components were assessed by quartiles of dietary phylloquinone intake.

Results: The lowest prevalence of MetS and its 5 components was observed in individuals with the highest phylloquinone intake. The prevalence of low high-density lipoprotein cholesterol (HDL) and elevated blood pressure progressively decreased with increasing phylloquinone intake (p < 0.05 for trend). HDL and C-reactive protein (CRP) levels improved gradually with increasing dietary phylloquinone intake (p < 0.05 for trend). In general, participants who had MetS or its element consumed less phylloquinone from diet compared those who did not. In comparison with the lowest phylloquinone intake quartile, the highest quartile of intake was associated with significantly reduced risks of low HDL level, hypertriglyceridemia, and hyperglycemia after adjustment was made for various nondietary confounding factors (OR, 0.73, 95% confidence interval [CI], 0.45-0.98; OR, 0.51, 95% CI, 0.25-0.97; and OR, 0.18, 95% CI, 0.05-0.73, respectively). Only the association between hyperglycemia and phylloquinone intake remained significant after further adjustment for dietary confounders (OR, 0.18, 95% CI, 0.05-0.73).

Conclusions: Mean reported dietary phylloquinone intakes suggested that most US young adults consume an insufficient amount of vitamin K from their diet. A high intake of phylloquinone may favorably affect MetS or its components, probably through an overall more heart-healthy dietary pattern. The pathogenesis of MetS is profoundly complex and may involve other factors and/or mechanisms, in addition to vitamin K nutriture. Although our data suggest a potential role of vitamin K in MetS, the biological mechanisms underlying the observed associations must be elucidated.

Citing Articles

An analysis of vitamin K status in Chinese healthy children aged 0-18 years.

Liu J, Chen L, Guo C, Feng Q, Cao R, Liu P BMC Pediatr. 2024; 24(1):703.

PMID: 39506667 PMC: 11539694. DOI: 10.1186/s12887-024-05195-y.


Vitamin K2 in Health and Disease: A Clinical Perspective.

Zhang T, OConnor C, Sheridan H, Barlow J Foods. 2024; 13(11).

PMID: 38890875 PMC: 11172246. DOI: 10.3390/foods13111646.


A causal relationship between antioxidants, minerals and vitamins and metabolic syndrome traits: a Mendelian randomization study.

Li J, Song F Diabetol Metab Syndr. 2023; 15(1):194.

PMID: 37817280 PMC: 10563368. DOI: 10.1186/s13098-023-01174-y.


Vitamin K-dependent carboxylation regulates Ca flux and adaptation to metabolic stress in β cells.

Lacombe J, Guo K, Bonneau J, Faubert D, Gioanni F, Vivoli A Cell Rep. 2023; 42(5):112500.

PMID: 37171959 PMC: 10305719. DOI: 10.1016/j.celrep.2023.112500.


Vitamin K2 (menaquinone-7) increases plasma adiponectin but does not affect insulin sensitivity in postmenopausal women: a randomized controlled trial.

Ronn S, Harslof T, Pedersen S, Langdahl B Eur J Clin Nutr. 2021; 75(11):1661-1667.

PMID: 33664429 DOI: 10.1038/s41430-021-00884-8.